This inventor holds 2 USPTO granted patents and 1 published patent application. Top assignee: Musc Foundation for Research Development. Active years: 2010-2011.
Location History:
- Mt. Pleasant, SC (US) (2010)
- Moncks Corner, SC (US) (2011)
Company Filing History:
Years Active: 2010-2011
Title: Michael Mitas: Innovator in Cancer Detection Technologies
Introduction
Michael Mitas is an accomplished inventor based in Moncks Corner, SC (US). He has made significant contributions to the field of cancer detection through his innovative patents. With a total of 2 patents, Mitas has focused on enhancing the methods used to diagnose and detect various forms of cancer.
Latest Patents
Mitas's latest patents include groundbreaking technologies aimed at improving cancer detection. One of his notable inventions is titled "Enhanced detection of RNA using a panel of truncated gene-specific primers for reverse transcription." This invention provides truncated gene-specific primers in panels that can be utilized during the reverse transcription step of RT-PCR. The goal is to increase signal detection of cancer gene markers in tissue samples. Additionally, the patent includes forward and reverse primers for RT-PCR, along with methods for using these primers effectively.
Another significant patent by Mitas is "Methods of using the primers are also provided." This patent outlines a method for detecting metastases of epithelial cancers. It involves detecting in non-primary tissue the overexpression of specific nucleic acids, which correlates with the presence of metastases in epithelial cancers. This innovative approach has the potential to enhance early detection and treatment options for patients.
Career Highlights
Michael Mitas is associated with the MUSC Foundation for Research Development, where he continues to work on advancing cancer research and detection technologies. His dedication to innovation in this field has positioned him as a key figure in the ongoing battle against cancer.
Collaborations
Mitas has collaborated with notable colleagues, including William E. Gillanders and David Cole. These partnerships have contributed to the development of his patents and the advancement of cancer detection methodologies.
Conclusion
Michael Mitas is a prominent inventor whose work in cancer detection technologies has the potential to significantly impact patient outcomes. His innovative patents reflect a commitment to improving diagnostic methods and enhancing the understanding of cancer biology.